Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer statistics for African American/Black People 2022
Angela N. Giaquinto, Kimberly D. Miller, Katherine Y. Tossas, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 3, pp. 202-229
Open Access | Times Cited: 449

Showing 1-25 of 449 citing articles:

Breast Cancer Statistics, 2022
Angela N. Giaquinto, Hyuna Sung, Kimberly D. Miller, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 6, pp. 524-541
Open Access | Times Cited: 1631
Epidemiology of Renal Cell Carcinoma: 2022 Update
Laura Bukavina, Karim Bensalah, Freddie Bray, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 529-542
Closed Access | Times Cited: 388
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening
John T. Wei, Daniel A. Barocas, Sigrid Carlsson, et al.
The Journal of Urology (2023) Vol. 210, Iss. 1, pp. 46-53
Open Access | Times Cited: 173
Bladder cancer
Lars Dyrskjøt, Donna E. Hansel, Jason A. Efstathiou, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 153
A Deep Learning Method for Breast Cancer Classification in the Pathology Images
Min Liu, Lanlan Hu, Ying Tang, et al.
IEEE Journal of Biomedical and Health Informatics (2022) Vol. 26, Iss. 10, pp. 5025-5032
Closed Access | Times Cited: 90
American Cancer Society’s report on the status of cancer disparities in the United States, 2023
Farhad Islami, Jordan Baeker Bispo, Hyunjung Lee, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 74, Iss. 2, pp. 136-166
Open Access | Times Cited: 45
Targeting Breast Cancer: An Overlook on Current Strategies
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3643-3643
Open Access | Times Cited: 40
Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: Advancements and future perspectives
Mohammad Sameer Khan, B.H. Jaswanth Gowda, Nazeer Hasan, et al.
European Polymer Journal (2024) Vol. 206, pp. 112800-112800
Closed Access | Times Cited: 20
Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer
Ling Ou, Hengrui Liu, Chang Peng, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37046-e37046
Open Access | Times Cited: 19
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance
Raffaella Casolino, Philip Beer, Debyani Chakravarty, et al.
CA A Cancer Journal for Clinicians (2024) Vol. 74, Iss. 3, pp. 264-285
Open Access | Times Cited: 16
Trends in Prostate Cancer Incidence and Mortality Rates
Erin L. Van Blarigan, Meg McKinley, Samuel L. Washington, et al.
JAMA Network Open (2025) Vol. 8, Iss. 1, pp. e2456825-e2456825
Open Access | Times Cited: 2
Somatic Genomic Profiling of Pancreatic Ductal Adenocarcinomas From a Diverse Cohort of Patients
Andrea N. Riner, Enrique Velazquez-Villarreal, Seeta Rajpara, et al.
Pancreas (2025) Vol. 54, Iss. 3, pp. e171-e178
Closed Access | Times Cited: 1
Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor–T Cell Therapy for Hematological Malignant Neoplasms
Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e228161-e228161
Open Access | Times Cited: 38
Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136021-136021
Closed Access | Times Cited: 35
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer
Calen Kucera, Chunqiao Tian, Christopher M. Tarney, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e238437-e238437
Open Access | Times Cited: 27
Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer
Kent Hoskins, Gregory S. Calip, Hsiao‐Ching Huang, et al.
JAMA Oncology (2023) Vol. 9, Iss. 4, pp. 536-536
Open Access | Times Cited: 23
Racial and ethnic disparities in a real-world precision oncology data registry
Alexander T. M. Cheung, Elina L. Palapattu, Isabella R. Pompa, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 22
Synthesis of 1-Piperoylpiperidine Investigated Through Spectroscopy, Quantum Computation, Pharmaceutical Activity, Docking and MD Simulation Against Breast Cancer
Kaliraj Chandran, Azar Zochedh, S. Asath Bahadur, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 6, pp. 3825-3859
Closed Access | Times Cited: 22
Trends in Uterine Cancer Mortality in the United States
Sahana Somasegar, Aya Bashi, Susan M. Lang, et al.
Obstetrics and Gynecology (2023)
Open Access | Times Cited: 22
Prostate Cancer Foundation Screening Guidelines for Black Men in the United States
Isla Garraway, Sigrid Carlsson, Yaw A. Nyame, et al.
NEJM Evidence (2024) Vol. 3, Iss. 5
Closed Access | Times Cited: 14
Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)
Heba T. Abdel‐Mohsen, Manal M. Anwar, Nesreen S. Ahmed, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 875-875
Open Access | Times Cited: 10
Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets
Amalia A. Sofianidi, Ecaterina E. Dumbrava, Konstantinos N. Syrigos, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1139-1139
Open Access | Times Cited: 9
Trends of Prostate Cancer Morbidity in Low-Incidence Countries from 1990–2019
Jinjiang Jiang, Bo Chen, Bo Tang, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 2, pp. 186-195
Open Access | Times Cited: 8
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
Hannah E. Woriax, Samantha M. Thomas, Jennifer K. Plichta, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1635-1645
Closed Access | Times Cited: 8
A Comparison of Prostate Cancer Screening Information Quality on Standard and Advanced Versions of ChatGPT, Google Gemini, and Microsoft Copilot: A Cross-Sectional Study
Otis L. Owens, Michael Leonard
American Journal of Health Promotion (2025)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top